The Effects of Fractional Carbon Dioxide (CO2) Laser Treatment Prior to Wound Closure
The recruitment status of this study is unknown because the information has not been verified recently.
Verified September 2009 by Moy-Fincher Medical Group.
Recruitment status was Not yet recruiting
Recruitment status was Not yet recruiting
Sponsor:
Moy-Fincher Medical Group
Information provided by:
Moy-Fincher Medical Group
ClinicalTrials.gov Identifier:
NCT00969475
First received: August 29, 2009
Last updated: September 13, 2009
Last verified: September 2009
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
The purpose of this study is to determine if fractional carbon dioxide laser treatment of a fresh wound at the time of surgery, decreases scar formation. Scar revision is commonly done at 6-10 weeks following surgery. Therefore, it may be more beneficial, for both the patient and physician, to perform scar revision at the time of surgery.
| Condition | Intervention |
|---|---|
|
Scars |
Device: Lumenis fractional carbon dioxide laser |
| Study Type: | Interventional |
| Study Design: | Allocation: Randomized Intervention Model: Crossover Assignment Masking: Single Blind (Outcomes Assessor) Primary Purpose: Treatment |
| Official Title: | The Effects of Fractional CO2 Resurfacing Prior to Complex Wound Closure |
Resource links provided by NLM:
Further study details as provided by Moy-Fincher Medical Group:
Primary Outcome Measures:
- Evidence of scar improvement as assessed by blinded-observer and patient ratings. [ Time Frame: At two and six weeks following the procedure ] [ Designated as safety issue: No ]
| Estimated Enrollment: | 10 |
| Study Start Date: | October 2009 |
| Estimated Study Completion Date: | December 2009 |
| Estimated Primary Completion Date: | December 2009 (Final data collection date for primary outcome measure) |
| Arms | Assigned Interventions |
|---|---|
|
No Intervention: Control
Half of each subject's wound will not be treated.
|
|
|
Experimental: Laser resurfacing
Half of each subject's wound will be treated with a fractional CO2 laser.
|
Device: Lumenis fractional carbon dioxide laser
intra-operative laser resurfacing at time of wound closure
Other Name: Lumenis
|
Eligibility| Ages Eligible for Study: | 18 Years to 70 Years |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | Yes |
Criteria
Inclusion Criteria:
- Undergoing skin cancer surgery
- Will have a straight-line incision
- Fluent in English
- Must reside in the Los Angeles vicinity for the duration of the study
Exclusion Criteria:
- Non-English speakers
- Pregnant or cognitively impaired subjects
Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00969475
Contacts
| Contact: Telia DeBoyes | tdeboyes@yahoo.com |
Locations
| United States, California | |
| Moy-Fincher Medical Group | Not yet recruiting |
| Los Angeles, California, United States, 90095 | |
| Contact 310-794-7422 | |
| Principal Investigator: David Ozog, MD | |
| Sub-Investigator: Edgar Fincher, MD | |
| Sub-Investigator: Ronald Moy, MD | |
| Sub-Investigator: Lisa Chipps, MD | |
Sponsors and Collaborators
Moy-Fincher Medical Group
Investigators
| Principal Investigator: | David Ozog, MD | Moy-Fincher Medical Group |
More Information
No publications provided
| Responsible Party: | Ronald Moy, MD, Moy-Fincher Medical Group |
| ClinicalTrials.gov Identifier: | NCT00969475 History of Changes |
| Other Study ID Numbers: | MF-01 |
| Study First Received: | August 29, 2009 |
| Last Updated: | September 13, 2009 |
| Health Authority: | United States: Institutional Review Board |
Keywords provided by Moy-Fincher Medical Group:
|
scar revision intraoperative fractional carbon dioxide laser |
Additional relevant MeSH terms:
|
Cicatrix Fibrosis Pathologic Processes |
ClinicalTrials.gov processed this record on May 19, 2013